Port communicationpatent medicine：The poll tax in modern society People，If you want to survive, you must eat and take medicine。So when faced with hunger and disease，Consumers do not have the ability to compare prices in the market。Now，The world's multinational pharmaceutical companies monopolize drug patents，Grain merchants monopolize seed patents，People eat and take medicine，We have to pay the food and drug interest groups.。The only inevitable things in life are death and taxes，Food and drug patent fees，In fact, it is a disguised poll tax.。 What are the prerequisites for market rules to take effect?
In "The Wealth of Nations"，Adam Smith mentioned，In an absolutely flat market，Buyers and sellers will have complete freedom of choice in both directions，This is called free competition in the market，The result of competition is that the division of labor in society becomes more and more refined.，Resource allocation efficiency is getting higher and higher，Total social productivity gradually increases。
On the other hand，When one of the parties between the buyer and the seller does not have the ability to choose，Or one party, the buyer or the seller, has formed an absolute monopoly.，Or when there is a huge information gap in market transactions，Market rules are bound to fail。 Therefore, the three prerequisites for market rules to take effect are ① the two-way option of buyers and sellers ② the degree of monopoly of buyers and sellers ③ the flatness of market information。
But market rules fail，It’s just that the productivity of the industry is reduced，
Advantages
Party’s profitability will be greatly improved，For profit-oriented companies，They naturally have no motivation to reverse market distortions。 And that's what's happening with pharmaceutical companies。 The pharmaceutical market completely fails to meet the three prerequisites for market rules to take effect.。
①Two-way options between buyers and sellers：Healthy people don’t try drugs for no reason，Sick people don’t have the opportunity to try medicine multiple times，between life and death，Patient has no choice，Either take medicine to save your life，Either don't eat and wait to die。 ②Monopoly：The pharmaceutical industry is an industry with extremely high technical thresholds，Medical students have to memorize the thickest books，The longest school，nature，Also looking forward to getting the highest income。So do pharmaceutical companies.，Various certifications、Review、Supervision is the best in the industry。
Market undercurrents，The bigger the boat, the more stable it is。The pharmaceutical market is in turmoil，Natural catalytic giant pharmaceutical company。When there are only less than a hundred super-large pharmaceutical companies left in the market，Monopoly is inevitable。 ③Information：Pharmaceutical market information is highly asymmetric。Medical identification requires extremely rich professional knowledge，The vast majority of consumers are bound to be confused when faced with medical instructions that are like a book.。
then，When Luo Yonghao opened a pharmaceutical factory to sell hammer anti-cancer drugs that were cured in one go，Do patients have the confidence to say I don’t want to buy it? but，Defenders for pharmaceutical companies often say，Drug prices are high because research and development costs are too high，One hundred thousand pills is not expensive，Because the first one is usually several billion。 This is a complete lie，Just take the United States, which has the most “developed” pharmaceutical industry, as an example.，We can know what the real source of profit is in the pharmaceutical industry。
The research and development costs of pharmaceutical companies are indeed not low.，However, the main preliminary work of new drug research and development is done by academia, which relies on public funds as its financial resources.。
Take Gleevec as an example，Finding the cause of disease since 1960 (Philadelphia chromosome)，By 1982, New Zealand scientist Annelies discovered that the oncogene C-ABL was translocated and fused with BCR to continuously activate tyrosine kinase.，This whole 22 years，The main force in R&D is academia，1988Year，Pharmaceutical companies only appear in the R&D process。 The biggest cost expenditure for pharmaceutical companies is not R&D，But a clinical trial。
The average cost of a clinical trial in the United States is $100,000，Not sure what the reason for this high cost is，But it's certain，A major factor in U.S. pharmaceutical companies’ desire to enter China，That’s because China’s clinical costs are very low。 So now the pharmaceutical company is more like a venture capital company，Giants directly acquire R&D results from academia or small companies。The giants themselves only do the R&D finishing work。The main job of giants is to do clinical work，Then pass FDA approval for listing。
That is to say，giant，In fact, it is a channel。 And the strangest thing about the whole thing is that，Includes various public funds funded by the federal government，When a drug is launched on the market，Not involved in pricing at all。
Giants are all channels，The way they monopolize channels is to join forces with Wall Street to lobby Washington.，In the end, the FDA established an approval process that was too stringent and complicated.，Small pharmaceutical companies built by academics and people in academia have to sell their research and development results to giants.，Even this exaggerated clinical cost of 100,000 per case， It is also a threshold deliberately set by the giants.。 Another fact is，Giants spend far more on patent legal counsel and lobbying than on R&D itself。
In addition to consolidating the profitability of one's own patents, this behavior，It can also block the launch of some drugs they don’t want to see.。For example, giants hate cures，Prefer life-sustaining medicine，Cocktail therapy to treat hepatitis B USD 400 per person，But was sniped by the patent。 This abnormal market structure maintains the high profits of giants，It is also an energy industry with public attributes.，Net profit margin is 2% to 4%，But the giants have 8% to 10%。
The academic community has completely proven that they can complete scientific research without the funding of giants.，Then the direction of reform is how to break through channels。Able to put the results of academia directly into medical treatment。Doing scientific research in academia，Non-profit organization doing clinical work，Independent third party supervision。 Cuba is a good case。
Medical care in Cuba is free，Therefore, the motivation of the medical institutions and academic circles is not to prescribe life-extending drugs to patients and permanently extract money.，But how to reduce the total cost of medical health for the whole society。 Bian Que mentioned in the conversation with the monarch，His eldest brother has the best medical skills，Before getting sick，The disease was cured，The second brother comes second，The disease can be cured in the early stage of sending troops，His worst，Only patients with obvious symptoms。but，In this way, he is the most famous，The second brother comes second，The eldest brother is almost unknown。
Cuba’s medical philosophy is that of Brother Bian Que。Try to prevent the occurrence of diseases in daily life. This is the lowest cost medical method.。 Thank you for browsing my article，Hope it helps you，If you want to know more, please pay attention to Qibangbang
About Hong Kong Xintong
Hong Kong Xintong focuses onGuangdong and Hong Kong license plates、Shenzhen Hazardous Chemicals Business License、Shenzhen labor dispatch licenseandShenzhen Charity Foundationapplication services，Assist customers to applyShenzhen travel agency business license、Shenzhen pawn shop business license、Shenzhen auction house license and other mainstream domestic financial licenses，Support enterprises to achieve compliance expansion of cross-border financial business。Also availableODI overseas investment registration、International travel agency registration and other services，Help enterprises expand their presence in international markets。Provide one-stop compliance solutions for enterprises。To learn more，Please contactHong Kong Information Communications Consultant。
